LIGAND-TARGETED LIPOSOMES DIRECTED AGAINST PATHOLOGICAL VASCULATURE
Raymond M. Schiffelers(University Medical Center Utrecht), Gert Storm(Yong In University), Gerben A. Koning(Università Cattolica del Sacro Cuore), Robbert J. Kok(Utrecht University), Adriënne P. C. A. Janssen(Pharmo Institute), Timo L.M. ten Hagen(Erasmus MC), Grietje Molema(University Medical Center Groningen), Astrid J. Schraa(University of Groningen)
Cited by 21
Related Papers
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
|Frontiers in Pharmacology|2018|937
TNF-α in Cancer Treatment: Molecular Insights, Antitumor Effects, and Clinical Utility
|The Oncologist|2006|711
Sheddable Coatings for Long-Circulating Nanoparticles
|Pharmaceutical Research|2007|549
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature
|Drug Resistance Updates|2005|461